253 related articles for article (PubMed ID: 10721857)
1. Accumulated p53 protein and UVA protection level of sunscreens.
Seité S; Moyal D; Verdier MP; Hourseau C; Fourtanier A
Photodermatol Photoimmunol Photomed; 2000 Feb; 16(1):3-9. PubMed ID: 10721857
[TBL] [Abstract][Full Text] [Related]
2. Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.
Fourtanier A; Moyal D; Seité S
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):164-74. PubMed ID: 18717957
[TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings.
Moyal DD; Fourtanier AM
J Am Acad Dermatol; 2008 May; 58(5 Suppl 2):S149-54. PubMed ID: 18410801
[TBL] [Abstract][Full Text] [Related]
4. A broad spectrum high-SPF photostable sunscreen with a high UVA-PF can protect against cellular damage at high UV exposure doses.
Cole C; Appa Y; Ou-Yang H
Photodermatol Photoimmunol Photomed; 2014 Aug; 30(4):212-9. PubMed ID: 24806442
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Diffuse Reflectance Spectroscopy: Non-Erythemal in vivo Testing of Sun Protection Factor.
Rohr M; Ernst N; Schrader A
Skin Pharmacol Physiol; 2018; 31(4):220-228. PubMed ID: 29791917
[TBL] [Abstract][Full Text] [Related]
6. Photoprotective efficacy and photostability of fifteen sunscreen products having the same label SPF subjected to natural sunlight.
Hojerová J; Medovcíková A; Mikula M
Int J Pharm; 2011 Apr; 408(1-2):27-38. PubMed ID: 21277959
[TBL] [Abstract][Full Text] [Related]
7. Prevention of ultraviolet-induced skin pigmentation.
Moyal D
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):243-7. PubMed ID: 15379874
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of broad-spectrum sunscreens against the suppression of elicitation of delayed-type hypersensitivity responses in humans depends on the level of ultraviolet A protection.
Moyal DD; Fourtanier AM
Exp Dermatol; 2003 Apr; 12(2):153-9. PubMed ID: 12702143
[TBL] [Abstract][Full Text] [Related]
9. UVA protection efficacy of sunscreens can be determined by the persistent pigment darkening (PPD) method. (Part 2).
Moyal D; Chardon A; Kollias N
Photodermatol Photoimmunol Photomed; 2000 Dec; 16(6):250-5. PubMed ID: 11132127
[TBL] [Abstract][Full Text] [Related]
10. p53 labeling index in assessing the efficacy of a sunscreen in protection against UV-induced damage.
Lens M; Bielfeldt S; Bataille V; Wilhelm KP
Int J Dermatol; 2008 Dec; 47(12):1234-9. PubMed ID: 19126007
[TBL] [Abstract][Full Text] [Related]
11. HDRS - Hybrid Diffuse Reflectance Spectroscopy: Non-Erythemal In Vivo Driven SPF and UVA-PF Testing.
Rohr M; Schrader A
Curr Probl Dermatol; 2021; 55():144-156. PubMed ID: 34698044
[TBL] [Abstract][Full Text] [Related]
12. Decreased p53 expression in chronically sun-exposed human skin after topical photoprotection.
Berne B; Pontén J; Pontén F
Photodermatol Photoimmunol Photomed; 1998; 14(5-6):148-53. PubMed ID: 9826884
[TBL] [Abstract][Full Text] [Related]
13. Protection of skin biological targets by different types of sunscreens.
Fourtanier A; Bernerd F; Bouillon C; Marrot L; Moyal D; Seité S
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):22-32. PubMed ID: 16436178
[TBL] [Abstract][Full Text] [Related]
14. Protection against pyrimidine dimers, p53, and 8-hydroxy-2'-deoxyguanosine expression in ultraviolet-irradiated human skin by sunscreens: difference between UVB + UVA and UVB alone sunscreens.
Liardet S; Scaletta C; Panizzon R; Hohlfeld P; Laurent-Applegate L
J Invest Dermatol; 2001 Dec; 117(6):1437-41. PubMed ID: 11886505
[TBL] [Abstract][Full Text] [Related]
15. The sun protection factor (SPF) inadequately defines broad spectrum photoprotection: demonstration using skin reconstructed in vitro exposed to UVA, UVBor UV-solar simulated radiation.
Bernerd F; Vioux C; Lejeune F; Asselineau D
Eur J Dermatol; 2003; 13(3):242-9. PubMed ID: 12804982
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products.
Beasley DG; Meyer TA
Am J Clin Dermatol; 2010 Dec; 11(6):413-21. PubMed ID: 20806994
[TBL] [Abstract][Full Text] [Related]
17. Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end point. (Part 1). Calibration of the method.
Moyal D; Chardon A; Kollias N
Photodermatol Photoimmunol Photomed; 2000 Dec; 16(6):245-9. PubMed ID: 11132126
[TBL] [Abstract][Full Text] [Related]
18. Sunscreens and their usefulness: have we made any progress in the last two decades?
Serpone N
Photochem Photobiol Sci; 2021 Feb; 20(2):189-244. PubMed ID: 33721254
[TBL] [Abstract][Full Text] [Related]
19. The effect of sunscreen on skin elastase activity induced by ultraviolet-A irradiation.
Tsukahara K; Moriwaki S; Hotta M; Fujimura T; Sugiyama-Nakagiri Y; Sugawara S; Kitahara T; Takema Y
Biol Pharm Bull; 2005 Dec; 28(12):2302-7. PubMed ID: 16327169
[TBL] [Abstract][Full Text] [Related]
20. New noninvasive approach assessing in vivo sun protection factor (SPF) using diffuse reflectance spectroscopy (DRS) and in vitro transmission.
Ruvolo Junior E; Kollias N; Cole C
Photodermatol Photoimmunol Photomed; 2014 Aug; 30(4):202-11. PubMed ID: 24417335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
